Antimicrobial peptides

WikiDoc Resources for Antimicrobial peptides

Articles

Most recent articles on Antimicrobial peptides

Most cited articles on Antimicrobial peptides

Review articles on Antimicrobial peptides

Articles on Antimicrobial peptides in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Antimicrobial peptides

Images of Antimicrobial peptides

Photos of Antimicrobial peptides

Podcasts & MP3s on Antimicrobial peptides

Videos on Antimicrobial peptides

Evidence Based Medicine

Cochrane Collaboration on Antimicrobial peptides

Bandolier on Antimicrobial peptides

TRIP on Antimicrobial peptides

Clinical Trials

Ongoing Trials on Antimicrobial peptides at Clinical Trials.gov

Trial results on Antimicrobial peptides

Clinical Trials on Antimicrobial peptides at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Antimicrobial peptides

NICE Guidance on Antimicrobial peptides

NHS PRODIGY Guidance

FDA on Antimicrobial peptides

CDC on Antimicrobial peptides

Books

Books on Antimicrobial peptides

News

Antimicrobial peptides in the news

Be alerted to news on Antimicrobial peptides

News trends on Antimicrobial peptides

Commentary

Blogs on Antimicrobial peptides

Definitions

Definitions of Antimicrobial peptides

Patient Resources / Community

Patient resources on Antimicrobial peptides

Discussion groups on Antimicrobial peptides

Patient Handouts on Antimicrobial peptides

Directions to Hospitals Treating Antimicrobial peptides

Risk calculators and risk factors for Antimicrobial peptides

Healthcare Provider Resources

Symptoms of Antimicrobial peptides

Causes & Risk Factors for Antimicrobial peptides

Diagnostic studies for Antimicrobial peptides

Treatment of Antimicrobial peptides

Continuing Medical Education (CME)

CME Programs on Antimicrobial peptides

International

Antimicrobial peptides en Espanol

Antimicrobial peptides en Francais

Business

Antimicrobial peptides in the Marketplace

Patents on Antimicrobial peptides

Experimental / Informatics

List of terms related to Antimicrobial peptides

## Contents

* 1 Overview
* 2 Structure
* 3 Antimicrobial Activities
* 4 Immunomodulatory Activities
* 5 Therapeutic Potential
* 6 Notes and references
* 7 External links
* 8 See also

## Overview

[edit | edit source]

Antimicrobial peptides (also called host defence peptides) are an evolutionarily conserved component of the innate immune response and are found among all classes of life.

These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria (including strains that are resistant to conventional antibiotics), mycobacteria (including Mycobacterium tuberculosis), enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears as though antimicrobial peptides may also have the ability to enhance immunity by functioning as immunomodulators.

## Structure

[edit | edit source]

Antimicrobial peptides are short proteins, generally between 12 and 50 amino acids long (although larger proteins with similar properties such as lysozyme are often classified as antimicrobial peptides). These peptides include two or more positively charged residues provided by arginine, lysine or, in acidic environments, histidine, and a large proportion (generally >50%) of hydrophobic residues.[1][2] The secondary structures of these molecules follow 4 themes, including i) α-helical, ii) β-stranded due to the presence of 2 or more disulphide bonds, iii) β-hairpin or loop due to the presence of a single disulphide bond and/or cyclization of the peptide chain, and iv) extended. Many of these peptides are unstructured in free solution, and fold into their final configuration upon partitioning into biological membranes. The ability to associate with membranes is a definitive feature of antimicrobial peptides [3] although membrane permeabilisation is not necessary. These peptides have a variety of antimicrobial activities ranging from membrane permeabilization to action on a range of cytoplasmic targets.

## Antimicrobial Activities

[edit | edit source]

The modes of action by which antimicrobial peptides kill bacteria is varied and includes disrupting membranes, interfering with metabolism, and targeting cytoplasmic components. In many cases the exact mechanism of killing is not known. In contrast to many conventional antibiotics these peptides appear to be bacteriocidal (bacteria killer) instead of bacteriostatic (bacteria growth inhibitor). In general the antimicrobial activity of these peptides is determined by measuring the minimal inhibitory concentration (MIC), which is the lowest concentration of drug that reduces growth by more than 50%.[4]

## Immunomodulatory Activities

[edit | edit source]

In addition to killing bacteria directly they have been demonstrated to have a number of immunomodulatory functions that may be involved in the clearance of infection, including the ability to alter host gene expression, act as chemokines and/or induce chemokine production, inhibiting lipopolysaccharide induced pro-inflammatory cytokine production, promoting wound healing, and modulating the responses of dendritic cells and cells of the adaptive immune response. Animal models indicate that host defence peptides are crucial for both prevention and clearance of infection. It appears as though many peptides initially isolated as and termed “antimicrobial peptides” have been shown to have more significant alternative functions in vivo (e.g. hepcidin [5]).

## Therapeutic Potential

[edit | edit source]

These peptides are excellent candidates for development as novel therapeutic agents and complements to conventional antibiotic therapy because in contrast to conventional antibiotics they do not appear to induce antibiotic resistance while they generally have a broad range of activity, are bacteriocidal as opposed to bacteriostatic and require a short contact time to induce killing. A number of naturally occurring peptides and their derivatives have been developed as novel anti-infective therapies for conditions as diverse as oral mucositis, lung infections associated with cystic fibrosis (CF) and topical skin infections.

## Notes and references

[edit | edit source]

1. ^ Papagianni, M. 2003. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol Adv 21:465.
2. ^ Sitaram, N., and R. Nagaraj. 2002. Host-defense antimicrobial peptides: importance of structure for activity. Curr Pharm Des 8:727.
3. ^ Hancock, R. E. W., and A. Rozek. 2002. Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett 206:143.
4. ^ National Committee of Laboratory Safety and Standards (NCLSS) as published in Amsterdam, D. 1996. Susceptibility testing of Antimicrobials in liquid media. In "Antibiotics in Laboratory Medicine", Lorian, V., ed. Fourth Edition, pp.52-111. Williams and Wilkins, Baltimore
5. ^ Hunter, H. N., D. B. Fulton, T. Ganz, and H. J. Vogel. 2002. The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis. J Biol Chem 277:37597.

## External links

[edit | edit source]

* A good basic overview of cationic peptides at scq.ubc.ca
* Review with helpful links at ejbiotechnology.info
* Antimicrobial Peptide Database at unmc.edu
* UMich Orientation of Proteins in Membranes classes/type-3 \- Calculated spatial positions of peptides in the lipid bilayer
* Antimicrobial+Cationic+Peptides at the US National Library of Medicine Medical Subject Headings (MeSH)

## See also

[edit | edit source]

Cathelicidin

Template:WH Template:WS